Technetium-99m-methylene disphosphonate (MDP) bone scan hypercalcemia.
Multifocal pyomyositis. Diagnosis on technetium-99m MDP bone scan.
Gallbladder visualization on a technetium-99m MDP bone scan.
Study of the Usefulness of Bone Scan Index Calculated From 99m-Technetium- Hydroxymethylene Diphosphonate ((99m)Tc-HMDP) Bone Scintigraphy for Bone Metastases from Prostate Cancer Using Deep Learning Algorithms.
Higashiyama S, Yoshida A, Kawabe J.
Curr Med Imaging. 2021;17(1):89-96. doi: 10.2174/1573405616666200528153453.
Technetium-99m APD compared with technetium-99m MDP as a bone scanning agent.
Degrossi OJ, Oliveri P, García del Río H, Labriola R, Artagaveytía D, Degrossi EB.
J Nucl Med. 1985 Oct;26(10):1135-9.
Technetium-99m MDP vs technetium-99m dicarboxypropane diphosphonate. A clinical comparison in various pathologic conditions.
Godart G, Durez M, Bevilacqua M, Abramovici J, Robience Y.
Clin Nucl Med. 1986 Feb;11(2):92-7. doi: 10.1097/00003072-198602000-00006.
Technetium-99m MDP scintigraphy. An insensitive tool for the detection of bone marrow metastases.
Gulenchyn KY, Papoff W.
Clin Nucl Med. 1987 Jan;12(1):45-6.
Adverse Clinical Events at the Injection Site Are Exceedingly Rare After Reported Radiopharmaceutical Extravasation in Patients Undergoing (99m)Tc-MDP Whole-Body Bone Scintigraphy: A 12-Year Experience.
Parihar AS, Schmidt LR, Crandall J, Dehdashti F, Wahl RL.
J Nucl Med. 2023 Mar;64(3):485-490. doi: 10.2967/jnumed.122.264994. Epub 2022 Oct 20.
Localization of technetium-99m methylene diphosphonate in bone using microautoradiography.
Einhorn TA, Vigorita VJ, Aaron A.
J Orthop Res. 1986;4(2):180-7. doi: 10.1002/jor.1100040206.
Altered Distribution of 99m Tc-MDP Bone Scintigraphy : Still Room Left for 99m Tc-Dextrose Interference?
Sharifian A, Qutbi M.
Clin Nucl Med. 2023 Sep 1;48(9):837-838. doi: 10.1097/RLU.0000000000004548. Epub 2023 Jan 14.
Technetium-99m-labeled antigranulocyte antibody bone marrow scintigraphy.
Lee KH, Chung JK, Choi CW, Jeong JM, Lee DS, Bang YJ, Lee MC, Kim NK, Koh CS.
J Nucl Med. 1995 Oct;36(10):1800-5.
Bone scan (99m)Tc-MDP imaging of malignant mesothelioma with osseous differentiation.
Kotsalou I, Chronopoulos P, Mella A, Zoumboulidis A, Dimakopoulos N.
Hell J Nucl Med. 2011 May-Aug;14(2):175-6.
Quantitative (99m)Tc-MDP SPECT/CT as an alternative to (18)F-NaF PET/CT for objective assessment of osteoblastic bone metastases.
Coskun N, Cagdas B, Yildirim N.
Hell J Nucl Med. 2022 May-Aug;25(2):132-137. doi: 10.1967/s002449912472. Epub 2022 Aug 3.
